Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2445858rdf:typepubmed:Citationlld:pubmed
pubmed-article:2445858lifeskim:mentionsumls-concept:C0021747lld:lifeskim
pubmed-article:2445858lifeskim:mentionsumls-concept:C1551336lld:lifeskim
pubmed-article:2445858lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:2445858pubmed:issue5lld:pubmed
pubmed-article:2445858pubmed:dateCreated1988-1-21lld:pubmed
pubmed-article:2445858pubmed:abstractTextOur views of interferon production and action have evolved from the simple to the complex. We review evidence that interferon-gamma (IFN-gamma) may induce a portion of its antiviral activity through the induction of another interferon. This is shown by demonstrating IFN-alpha in the supernatant fluids of IFN-gamma-treated mouse cells and showing that, under certain conditions, the antiviral activity of IFN-gamma in mouse and human cells can be reduced by antibody to IFN-alpha or IFN-beta, respectively. Induction of mouse spleen, bone marrow, and peritoneal exudate cells also results in their production of IFNs-alpha and/or -beta. In addition, new preliminary data indirectly suggests the presence of IFN-gamma in poly(IC):poly(LC)-treated mouse cells. In both of these systems, the maximal antiviral activity appears to develop as a consequence of the induction of a second interferon.lld:pubmed
pubmed-article:2445858pubmed:languageenglld:pubmed
pubmed-article:2445858pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2445858pubmed:citationSubsetIMlld:pubmed
pubmed-article:2445858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2445858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2445858pubmed:statusMEDLINElld:pubmed
pubmed-article:2445858pubmed:monthOctlld:pubmed
pubmed-article:2445858pubmed:issn0197-8357lld:pubmed
pubmed-article:2445858pubmed:authorpubmed-author:BaronSSlld:pubmed
pubmed-article:2445858pubmed:authorpubmed-author:HughesT KTKlld:pubmed
pubmed-article:2445858pubmed:issnTypePrintlld:pubmed
pubmed-article:2445858pubmed:volume7lld:pubmed
pubmed-article:2445858pubmed:ownerNLMlld:pubmed
pubmed-article:2445858pubmed:authorsCompleteYlld:pubmed
pubmed-article:2445858pubmed:pagination603-14lld:pubmed
pubmed-article:2445858pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2445858pubmed:meshHeadingpubmed-meshheading:2445858-...lld:pubmed
pubmed-article:2445858pubmed:meshHeadingpubmed-meshheading:2445858-...lld:pubmed
pubmed-article:2445858pubmed:meshHeadingpubmed-meshheading:2445858-...lld:pubmed
pubmed-article:2445858pubmed:meshHeadingpubmed-meshheading:2445858-...lld:pubmed
pubmed-article:2445858pubmed:meshHeadingpubmed-meshheading:2445858-...lld:pubmed
pubmed-article:2445858pubmed:year1987lld:pubmed
pubmed-article:2445858pubmed:articleTitleDo the interferons act singly or in combination?lld:pubmed
pubmed-article:2445858pubmed:affiliationDepartment of Microbiology, University of Texas Medical School, Galveston 77550.lld:pubmed
pubmed-article:2445858pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2445858pubmed:publicationTypeReviewlld:pubmed
pubmed-article:2445858pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2445858lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2445858lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2445858lld:pubmed